Skip to content

Yuanhuang “Harry” Chen, MS

Yuanhuang Chen_PDDS26
Predoctoral Fellowship in Drug Discovery, 2026 Rockefeller University

Elucidating the Role of Cysteinyl Leukotrienes (CysLTs) in Cancer and Aging

Abstract

Cysteinyl leukotrienes (CysLTs) are inflammatory lipid mediators that signal primarily through the G protein-coupled receptors (GPCRs) CysLTR1 and CysLTR2. Recently, a mutant form of CYSLTR2 (the gene encoding CysLTR2) was discovered to drive cell proliferation in uveal melanoma (UM) and dermal blue nevi. However, it has been suggested that CysLTR2 signaling is highly dependent on the cellular microenvironment. For example, paracrine signaling within the skin microenvironment can regulate melanocyte responses to oncogenic mutations. In fact, CysLTs have been identified as components of the senescence-associated secretory phenotype (SASP), which responds to oxidative stress. This study aims to elucidate the role of CysLTs signaling in promoting either proliferation or senescence of melanocytes. Findings from this research could validate CysLTRs as drug targets for therapeutic interventions in the prevention and treatment of melanoma and pigmentation disorders.

The award provides added motivation for me to discover signaling pathways at the interface of aging and cancer that might lead to new therapeutic strategies.

Yuanhuang "Harry" Chen, MS

Related Links

PhRMA Foundation
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.